4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-034785
Chief Financial Officer sold 14,000 shares at $11.00 ($154,000)
- Chief Financial Officer acquired 14,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2018-05-30 | Option exercise | +1,400 | $2.01 | $2,814 | 312,215 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2018-05-30 | Sale | −1,400 | $11.00 | $15,400 | 310,815 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2018-05-31 | Option exercise | +12,600 | $2.01 | $25,326 | 323,415 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2018-05-31 | Sale | −12,600 | $11.00 | $138,600 | 310,815 | D |
| Derivatives | |||||||
| Myszkowski Kenneth Allen Chief Financial Officer | 2018-05-30 | Option exercise · Stock Option (right to buy) | −1,400 | 320,600 | D | ||
| Myszkowski Kenneth Allen Chief Financial Officer | 2018-05-31 | Option exercise · Stock Option (right to buy) | −12,600 | 308,000 | D | ||
| Open-market sales · 14,000 sh · avg $11.00 · $154,000 | |||||||
Loading xslF345X03/doc4.xml…